Search Results - "pharmacokinetics"

Pediatric growth patterns in youth‐onset type 2 diabetes mellitus: Implications for physiologically‐based pharmacokinetic models by Chelsea M. Hosey, Kelsee Halpin, Valentina Shakhnovich, Chengpeng Bi, Brooke Sweeney, Yun Yan, J. Steven Leeder

Connect to this object online.

Clinical Ocular Exposure Extrapolation for a Complex Ophthalmic Suspension Using Physiologically Based Pharmacokinetic Modeling and Simulation by Maxime Le Merdy, Jessica Spires, Ming-Liang Tan, Liang Zhao, Viera Lukacova

Connect to this object online.

Common Errors Related to Vancomycin Pharmacokinetics, Prescribed by Physicians in Iran: Suggesting Practical Approaches for Adjusting the Right Dose by Saghar Barati, Zahra Sahraei

Connect to this object online.

The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics by Qiuxia Yu, Minhua Li, Hanbin Chen, Lieqiang Xu, Juanjuan Cheng, Guoshu Lin, Yuhong Liu, Ziren Su, Xiaobo Yang, Yucui Li, Jiannan Chen, Jianhui Xie

Connect to this object online.

Cytochrome P450 2D6 genotype-phenotype characterization through population pharmacokinetic modeling of tedatioxetine by Trine Frederiksen, Johan Areberg, Ellen Schmidt, Tore Bjerregaard Stage, Kim Brøsen

Connect to this object online.

Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates by Maria Eugenia Gallo Cantafio, Boye Schnack Nielsen, Chiara Mignogna, Mariamena Arbitrio, Cirino Botta, Niels M Frandsen, Christian Rolfo, Pierosandro Tagliaferri, Pierfrancesco Tassone, Maria Teresa Di Martino

Connect to this object online.

Correction: Pharmacokinetics of Naja sumatrana (Equatorial Spitting Cobra) Venom and Its Major Toxins in Experimentally Envenomed Rabbits

Connect to this object online.

An effective UFLC-MS/MS method used to study pharmacokinetics of major constituents of Fukeqianjin formula in rat plasma by Kanghua Wang, Lu Liu, Yanfang Yang, Xiaoyan Liu, Lei Zhang, Wei Xu, Yingtao Zhang, Xiuwei Yang, Peng Zhang, Kaifeng Peng, Yun Gong, Nifu Liu

Connect to this object online.

Pharmacokinetic‐pharmacodynamic modelling of the anti‐FcRn monoclonal antibody rozanolixizumab: Translation from preclinical stages to the clinic by Rocio Lledo‐Garcia, Kate Dixon, Anthony Shock, Ruth Oliver

Connect to this object online.

Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects by Wang J, Zhang H, Wang R, Cai Y

Connect to this object online.

A phase I, first‐in‐human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937 by Paul D. Benn, Ying Zhang, Lesley Kahl, Thomas J. Greene, Veronica Bainbridge, Cindy Fishman, Bo Wen, Martin Gartland

Connect to this object online.

Predicting Maternal and Infant Tetrahydrocannabinol Exposure in Lactating Cannabis Users: A Physiologically Based Pharmacokinetic Modeling Approach by Babajide Shenkoya, Venkata Yellepeddi, Katrina Mark, Mathangi Gopalakrishnan

Connect to this object online.

Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance by Christina König, Anna Both, Holger Rohde, Stefan Kluge, Otto R. Frey, Anka C. Röhr, Dominic Wichmann

Connect to this object online.

A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects by Kim HC, Lee S, Sung S, Kim E, Jang IJ, Chung JY

Connect to this object online.

The randomized, single‐ and multiple‐ ascending dose studies of the safety, tolerability, pharmacokinetics of CSPCHA115 in healthy Chinese subjects by Shan Jing, Wenfang Liu, Kexu Yang, Yang Lin, Xuekun Yao, Guilan Sun

Connect to this object online.

Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens by Xingchen Bian, Xingchen Bian, Xingchen Bian, Xingchen Bian, Xiaofen Liu, Xiaofen Liu, Xiaofen Liu, Fupin Hu, Meiqing Feng, Yuancheng Chen, Phillip J. Bergen, Jian Li, Xin Li, Xin Li, Xin Li, Yan Guo, Jing Zhang, Jing Zhang, Jing Zhang, Jing Zhang

Connect to this object online.

Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study by Rong Deng, Leonid Gibiansky, Tong Lu, Christopher R. Flowers, Laurie H. Sehn, Qi Liu, Priya Agarwal, Michael Z. Liao, Randall Dere, Calvin Lee, Gabriel Man, Jamie Hirata, Chunze Li, Dale Miles

Connect to this object online.

The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study by Kuo Hsin-Chih, Hsu Chao-Chin, Hsu Chao-Tien, Gu Qing

Connect to this object online.

Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment by Amy Q. Wang, Natalie R. Hagen, Elias C. Padilha, Mengbi Yang, Pranav Shah, Catherine Z. Chen, Wenwei Huang, Pramod Terse, Philip Sanderson, Wei Zheng, Xin Xu

Connect to this object online.

Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease by Niurys de Castro-Suárez, Mirjam N. Trame, Mayra Ramos-Suzarte, José M. Dávalos, Raymed A. Bacallao-Mendez, Anaelys R. Maceo-Sinabele, Víctor Mangas-Sanjuán, Gledys Reynaldo-Fernández, Leyanis Rodríguez-Vera

Connect to this object online.